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requested to undergo an EMG exam. However, the suspected diagnosis is not always told to the
electromyography practitioner, who must be able to recognize such a condition to avoid false positive
diagnosis without dismissing the possibility to uncover any true dysfunction. There are many clinical
manoeuvers to assess the consistency of the patients’ reported weakness or sensory deficit. The electro-
diagnostic practitioner should be aware of those clinical tricks and interpret the electrodiagnostic
findings in the clinical context. There are many electrodiagnostic tests that the practitioner can use for
the assessment of motor and sensory functions but these tests have also important drawbacks and
limitations. Only after a good clinical evaluation would the practitioner be able to give his/her opinion
on the clinical relevance of the electrodiagnostic findings. Here we review some of the tests that can help
the practitioner to define the electrophysiological characteristics of a suspected functional disorder
presenting with weakness or sensory deficit.
 2016 Published by Elsevier B.V. on behalf of International Federation of Clinical Neurophysiology. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).Contents1. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
2. Functional weakness . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32.1. Motor nerve conduction studies. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
2.2. Transcranial magnetic stimulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
2.3. Needle electromyography . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53. Sensory deficit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
3.1. Sensory nerve conduction studies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
3.2. Somatosensory evoked potentials . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
3.3. Prepulse and gating effects . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 74. Conclusions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
Conflict of interest statement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 71. Introduction
Loss of strength or sensation are two of the most common
symptoms for referral of patients to electrodiagnostic testing. The
examiner can use a variety of techniques in search of a pathophys-
iological explanation for those symptoms compatible with the
clinical context. In theory, the examiner carrying out electrodiag-
nostic tests should report on objective parametric data, with as
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whole spectrum of paraclinical tests in light of the clinical evalua-
tion. Today’s electrodiagnostic tools allow for assessment of many
sensory and motor segments, including central tracts and
peripheral nerves and, therefore, there are many possibilities for
a dedicated electrodiagnostic expert to find the clinical-
neurophysiological correlate of the disorder in question.
Unfortunately, though, time constraints in busy clinics and
patient compliance generally limits the number of electrodiagnos-
tic tests that can be performed. Furthermore, the expert in electro-
diagnostic medicine knows that the results obtained make sense
only if the tests performedwere based on a clinical logic. To do that,
the electrodiagnostic practitioner has to use data from patient’s his-
tory and physical examination to decide on the steps of further test-
ing and finally issue a clinically relevant report. Often, the referral
note is not sufficient. The examiner should be aware of the possibil-
ity that some relevant symptoms and signs, not necessarily stated
in the referral, are very relevant for the outcome of the study.
Indeed, the electrodiagnostic examiner is the one ultimately
responsible for the report, whatever be the syndrome that led to
the patient’s presentation for the examination. In fact, a good elec-
trodiagnostic practitioner should have a thorough technical and
clinical expertise, together with the necessary writing skills to be
able to transmit to the referring physician his/her opinion beyond
just cold data. Good practice in electrodiagnostic medicine contem-
plates as much refraining from raising clinically unfounded suspi-
cions as not letting pass by clinically undiagnosed syndromes in
which the electrodiagnostic tests play a relevant role.
Among the syndromes challenging the capacity of the electrodi-
agnostic practitioner are the medically unexplainable symptoms
that affect the nervous system (Carson et al., 2000). The term
psychogenic has been used for many years to describe this type of
disorder but the more convenient term ‘functional disorders’ is
now recommended (Stone and Carson, 2011). That a given disorder
is functional and not derived from a recognizable neurological
disorder is not a straightforward diagnosis. The clinical expression
of some neurological disorders may be modified by will or
adaptation, either amplifying or reducing the symptoms known to
characterize the disorder. Compensatory mechanisms may be at
play, which may modify the clinical expression in a way unknown
to the patient, and sometimes also to the physician. On some occa-
sions, the presence of a psychogenic disordermasks the diagnosis of
a neurological disease with similar symptoms, as has been the case
in a percentage of patients in many series of patients with func-
tional neurological disorders reported so far. Finally, symptoms
may derive from true psychiatric dysfunctions such as conversion
disorder or hypochondria, or from disease-unrelated conditions,
such as factitious disorders or malingering (Hallett, 2006, 2010).
Table 1 summarizes the classification of the medically unexplained
syndromes, according to the certainty of the diagnosis.Table 1
Classification of the medically unexplained syndromes.
Category Definition
Possible Symptoms consistent and congruous with a known disease
but signs of obvious emotional disturbance or secondary
gain
Probable Symptoms consistent and congruous with a known disease
but the patient has traits of psychogenicity or a psychiatric
disorder
Clinically
established
Symptoms are inconsistent and incongruent and the patient
shows psychogenic signs, somatizations or psychiatric
condition
Documented Symptoms are completely relieved by placebo or the
patient is witnessed to be free of symptoms when feeling
unobserved
Adapted from Williams et al. (1995).Most reports on medically unexplainable symptoms in neuro-
logy have dealt with functional movement disorders, which have
attracted the attention of researchers for a long time (Fahn and
Williams, 1988; Koller et al., 1989; Lang et al., 1995; Stone et al.,
2002, 2005; Hallett, 2006, 2010; Edwards and Bhatia, 2012;
Ricciardi et al., 2015a). Research in this area has led to the
development of interesting electrodiagnostic tests to uncover the
voluntary nature of some apparently involuntary movements
(Hallett, 2010). This is the case for myoclonus (Thompson et al.,
1992; Brown and Thompson, 2001), tremor (O’Suilleabhain and
Matsumoto, 1998; Kumru et al., 2004) and in some forms of
dystonia (Schwingenschuh et al., 2011; Macerollo et al., 2015a).
These patients are commonly referred for specific electrodiagnostic
studies, in search of laboratory support for a clinically-based
diagnostic suspicion of functional disorder. This is indeed an
attractive challenge for researchers in the various neurophysiolog-
ical techniques that characterize voluntary and involuntary
movements. However, the electrodiagnostic examiner often faces
situations in which patients complain of weakness or sensory
deficit with uncertain diagnosis. In many countries, the physician
referring the patient for an electrodiagnostic study may not be a
neurologist, and he/she may hope that the electrodiagnostic
examination shows clearly if the motor or sensory deficit described
by the patient is related or not to a known neurological disorder, to
decide on the next step. It is therefore the responsibility of the
electrodiagnostic examiner to use all clues available to build up
his/her opinion on the case, including history and physical
examination data (Hallett, 2016) to finally write a sensible report
on the patient’s case. What follows is a review of the clinical and
electrodiagnostic clues that the electrodiagnostic expert may use
to determine whether or not the patient’s symptoms of weakness
and sensory deficit are related to a neurological disorder or are
non-neurological in nature.
2. Functional weakness
According to Stone et al. (2010), functional weakness is defined
as weakness that is both internally inconsistent and incongruent
with any recognizable neurological disease. They described the
incidence, demographic and clinical characteristics of 107 cases.
They found that patients with functional weakness were as
disabled as patients with weakness due to neurological disease.
The most common manifestation of functional weakness is
hemiparesis (79% of the 107 cases studied by Stone et al. (2010)).
However, there may be many other forms of presentation, includ-
ing weakness of distal or proximal limb segments. There are many
exploratory tricks to uncover functional weakness (Stone et al.,
2012; Tremolizzo et al., 2014). Close observation of how the
patient activates the supposedly paretic limb during postural tasks
may already be very informative. When the suspected psychogenic
weakness affects one leg only, the Hoover’s maneuver and the
abductor’s sign (Sonoo, 2004) may be very helpful. In Hoover’s
maneuver, the subject fails to press against the bed with the
healthy leg when requested to raise the weak one. In the abductor’s
sign, the subject fails to fix the non paretic leg in a neutral position
when requested to abduct the weak leg, while he/she is holding the
paretic leg in a fixed straight position when requested to abduct
the non-paretic one (see Sonoo (2004 for a graphical explanation
of the maneuver). When supposedly psychogenic weakness affects
both feet, some useful clinical information can be obtained by
observing whether or not synkinetic movements occur in the
upper limbs in the attempts to dorsiflex the toes. This is indeed
the case shown in Fig. 1, where the patient with true weakness
of dorsiflexion of the feet showed an involuntary extension of
the hand and fingers accompanying his unsuccessful efforts to
counteract the resistance offered by the examiner’s hands
Fig. 1. Ipsilateral upper limb synkinesis in weak foot dorsiflexion. The patient was a
62 y.o. man with severe polyneuropathy associated with liver cirrhosis and
cryoglobulinemia. His strength for foot and toes dorsiflexion were 3 over 5 (barely
able to raise them against gravity). When trying hard (lower picture), his fingers
raised involuntarily (arrow).
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indeed trying hard to perform the requested task. Such synkinesis
is usually absent in patients who fake weakness and, therefore, its
presence may be taken as a sign of true weakness. Similar signs can
be used for upper limbs where homonymous synkinetic move-
ments have been described in the contralateral hand when trying
hard to abduct the index finger against resistance in unilateral
tasks (Tinazzi et al., 2008). The electrodiagnostic approach to
examine weakness entails various steps, outlined below.
2.1. Motor nerve conduction studies
It is convenient to begin the electrodiagnostic examination for
the study of weakness by assessing possible peripheral neuropathyFig. 2. Peroneal nerve compound muscle action potentials (CMAP) recorded over the tibia
digitorum brevis (EDB) after stimulation at the ankle (B and D). Recordings come from tw
suffered from mononeuritis multiplex in the context of a connectivopathy-related vascu
dorsiflexion foot and toes strength (5/5). The patient on the right side (normal CMAP in ED
tibialis anterior, with a foot dorsiflexion strength of 4/5.as its cause. The amplitude of the compound muscle action
potential (CMAP) reflects the number of motor units activated at
the site of the stimulus. However, it may be difficult to know if loss
of amplitude can explain the symptoms in a given case. Obviously,
the examiner should have normative values obtained with the
same technique and examination conditions and, thus, determine
if the amplitude values obtained in that case are significantly
different from the norm. However, it has to be taken into account
that the CMAP recorded from a given muscle does not represent all
muscles contributing to the movement or task where weakness
can be observed. This is, for instance, the case with dorsiflexion
of the foot and toes. The main agents for these tasks are the tibialis
anterior and the extensor digitorum (and hallucis) longus. The
extensor digitorum brevis (EDB) is the muscle where conduction
of the common peroneal nerve is usually assessed, but it
contributes only slightly to toe dorsiflexion. In fact, weak foot
dorsiflexion is compatible with a normal CMAP in the EDB, as in
a case of L5 radiculopathy, while preserved foot dorsiflexion can
occur with an absent CMAP in the EDB, as in a case of vasculitis
involving just the most distal segment of the peroneal nerve
(Fig. 2).
The shape of the CMAP is a measure of dispersion of the nerve
volley. Weakness may result from lack of synchronization of inputs
to muscle fibers of different motor units, as in nerve demyelina-
tion. Slowness of nerve conduction velocity (NCV) may or may
not be present but, usually, a slow NCV does not explain per se
clinically relevant weakness (Cros and Triggs, 1996; Gordon and
Wilbourn, 2001). To evaluate dispersion, the examiner has to take
into account a few points. One is the distance between stimulation
and recording because dispersion increases with distance (Taylor,
1993). Finding some irregularities in the waveform to proximal
nerve stimulation may not be enough to consider the nerve studied
as abnormal. When in doubt, the evaluation of the F wave becomes
handy because it will show increased chronodispersion if the irreg-
ularities in the CMAP waveform are relevant (Vucic et al., 2007;
Harbo et al., 2008). Conduction block may give rise to weakness
more often than dispersion. This can be the case in early
Guillain–Barré syndrome, where the CMAP obtained to distal
stimulation may be preserved even in cases with complete
paralysis caused by proximal conduction block. Again, the evalua-
tion of the F wave is necessary in these cases. Certainly, the exam-
iner cannot draw firm conclusions from a normal CMAP to distal
stimulation. Normal shape, lack of dispersion and conduction
block as well as normal F wave latency, perseverance andlis anterior (TA) after stimulation at the fibular head (A and C) and over the extensor
o different persons. The patient on the left (normal CMAP in TA but reduced in EDB)
litic lesion and had marked atrophy of the extensor digitorum brevis but preserved
B but reduced in TA) suffered from L5 radiculopathy and had marked atrophy of the
Fig. 3. Differences in motor central conduction time (CCT) between right and left
sides in a patient with weakness in his left arm due to a small right cortical infarct.
CCT values, calculated by subtracting the latency of the responses obtained to
foraminal cervical stimulation from those obtained to cortical stimulation, are
indicated for each side.
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conclusion of normal motor nerves in a given territory.2.2. Transcranial magnetic stimulation
Weakness is more likely to happen with lesions involving the
corticospinal tract. There are many maneuvers to use in the
physical examination of a suspected disorder of corticospinal
conduction. However, pyramidal signs may not be present or may
be disguised by the concomitant presence of other neurological or
non-neurological lesions. Therefore, it is convenient to use neuro-
physiological tools to assess corticospinal tract function. The most
useful technique is transcranial magnetic stimulation (TMS), which
consists of a non-painful activation of the corticospinal system to
collect motor evoked potentials (MEPs) from the muscles suspected
to show the dysfunction. For detailed methodological issues and
guidelines for clinical applicability, the reader is addressed to the
many reviews on the subject, such as Rossi et al. (2009), Groppa
et al. (2012), Rossini et al. (2015) or others.
A useful measure to take from TMS studies is central motor con-
duction time, which is the subtraction of the peripheral conduction
time from the latency of the responses to cortical stimulation.
Again, every examiner should have normative reference values
for comparison. The assessment may be more straightforward
when the weakness is unilateral because of comparison to the con-
tralateral side (Fig. 3). Unfortunately, weakness does not correlate
with the abnormalities in central conduction time and there is
even the possibility that some motor impairment is due to premo-
tor disorders (Chamorro et al., 1997). However, in most instances,
normal MEP amplitude and central motor conduction time can rule
out the involvement of the pyramidal tract as a cause of weakness.
In doubtful situations, it may be convenient to ask the patient to
perform a sustained muscle contraction. Several signs of voluntary
facilitation can be detected in the MEP, including shortening of
onset latency, increase of peak-to-peak amplitude and lengthening
of duration. Some of these signs may be absent in patients with
functional paralysis, particularly the absence of an increase in
duration of the MEP beyond that at rest, one of the most significant
differences with respect to healthy subjects (Brum et al., 2016).
TMS during voluntary contraction allows analysis of the silent
period, and this may also give hints for suspected psychogenicity,
due to an irregularly sustained level of muscle contraction. In thiscase, the duration of the silent period may vary substantially from
one trial to the next. Obviously, clinical assessment is again of
paramount importance, not to mistake an impaired voluntary drive
for psychogenicity in patients with basal ganglia diseases, such as
Parkinson’s disease, Huntington’s disease or dystonia, where
irregularities in muscle contraction and in the duration of the silent
period to TMS have also been described (Priori et al., 1994;
Modugno et al., 2001; Rona et al., 1998).
2.3. Needle electromyography
One of the most troubling neurological disorders presenting
with generalized weakness is motoneuron disease. It may not be
the most frequent presentation, but patients with motoneuron dis-
ease may have only weakness, and there may be few or no relevant
physical signs if fasciculations are not evident. Certainly, subtle
clinical signs may not be passed unnoticed by an expert neurolo-
gist, but the suspicion of functional weakness may be raised in
cases with equivocal history data. It is not uncommon that an
electromyographer receives a patient with undiagnosed weakness
and he/she is the first to include motoneuron disease in the list of
diagnoses to take into account. This is a situation in which the
electromyographer needs all information available to reach the
correct diagnosis and is arguably the area where the diagnostic
errors derived from EMG examinations have important clinical
consequences. Errors can occur in both directions. Reporting a
normal examination in a patient with motoneuron disease may delay
the diagnosis (Nzwalo et al., 2014), while overinterpreting some EMG
data to give the erroneous positive diagnosis of motoneuron disease
in a patient with another less alarming neurological disorder could
lead to unnecessary worry, concern and expense.
Needle EMG examinations are necessary for the differential
diagnosis of weakness. The finding of denervation signs at rest is
undoubtedly the most important of all data gathered from needle
EMG. In this respect, it is adequate to remind that fasciculation
potentials are considered a sign of denervation in patients with
suspected motoneuron disease, according to the recently intro-
duced Awaji criteria (De Carvalho et al., 2008; Costa et al., 2012;
De Carvalho and Swash, 2013). Muscles to be examined should
be decided according to clinical presentation but the electromyog-
rapher may recognize that EMG of some muscles is usually more
informative than others. For instance, the finding of a slightly
reduced interference pattern in certain muscles such as gastrocne-
mii or quadriceps may not necessarily put them into the category
of denervated muscles. However, these findings in other muscles
such as the tibialis anterior, should be considered relevant and lead
to physical re-examination and history re-evaluation in the case of
suspected functional weakness. For the evaluation of the eventual
neurogenic deficit during contraction, the examiner has to take
into account that pyramidal tract dysfunction may mask the deficit
because of inconsistent and insufficient motor drive to amotoneu-
rons during voluntary contraction. Such inadequate activation of a
motoneurons is unfortunately similar to what would happen in
patients with functional weakness. The bottom line is that the
expected increase in motor unit firing frequency in a patient with
early motoneuron disease may not always be apparent.
3. Sensory deficit
Patients with functional neurological disorders may present
with sensory deficit. This may be congruous or not with a neuro-
logical distribution. Physical examination would easily rule out a
neurological disorder if the sensory deficit is inconsistent with a
known neurological syndrome. Neurophysiological assessment
may certainly help by recording the sensory nerve action poten-
tials (SNAPs) of the nerves supposedly damaged to compare them
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examiner should take into account the possibility of referred sen-
sations, which are typically dysesthetic. These may occur in some
known situations such as the upper-limb dysesthesias related to
heart disease, but it may occur in less well-known situations. Hip
damage may create a referred sensation along the leg, distributed
in the antero-lateral side of the thigh, mimicking meralgia pares-
thetica. And facial pain/paresthesias can originate from irritation
of the trigeminal nerve at the alveolar or dental branches. No
neurophysiological studies are available at present to disclose irri-
tation of a nerve giving rise to these ‘‘positive” referred sensations.
A very relevant dysfunction in the sensory domain has been
recently described in patients with functional movement
disorders, which could explain some of the features of clinical
presentation in these patients. This is the loss of sensory attenua-
tion during performance of voluntary movements (Pareés et al.,
2014). Reduction of intensity of sensation during self-generated
movements allows for developing a normal sense of agency. The
absence of such a reduction may explain why patients with
functional movement disorders feel the movements as involuntary
(Edwards et al., 2011; Kranick et al., 2013). Other disorders of
sensation have been reported in patients with functional move-
ment disorders, namely the alteration of interoceptive awareness
(Ricciardi et al., 2015b) and the difficulty in recognizing their
own emotional state, or alexithymia (Demartini et al., 2014). Such
high order sensory disturbances may be important for the patho-
physiology of functional neurological disorders but, in agreement
with its own nature, they are unnoticed and, therefore, unreported,
by the patients themselves. Reporting sensory deficit is a common
manifestation of functional disorders whether combined or not
with weakness. Distracting the patient’s attention while testing
eventual reactions to sensory stimuli in an area supposed to be
devoid of sensation is a clinical trick that can be useful in some
instances but neurophysiological examination is indeed very
relevant in this domain.
3.1. Sensory nerve conduction studies
Assessment of sensory nerve conduction is a basic study to
perform in any patient reporting sensory deficit. Routinely, the
examination of common nerves of the lower and upper limbs
(sural, superficial peroneal, median and ulnar should be done
bilaterally). If there is suspicion of distal neuropathies it may be
adequate to study more distal nerves in the feet (dorsal sural, the
distal branch of the deep peroneal nerve or medial/lateral plantar
nerves). Focal loss of sensation is not a common report in func-
tional neurological disorders but the examiner should anyway
pay attention to an eventual asymmetric decrease of sensory nerve
action potential (SNAP) amplitude, since mononeuritis multiplex
could actually explain some apparently incongruous sensory
signs combining hypesthesia and pain in unrelated regions
(Collins et al., 2013). If the sensory deficit relates to proximal
lesions, SNAPs of distal limb nerves may remain preserved. This
is usually the case with radiculopathies due to a herniated disk,
where the lesion is frequently at a preganglionic level, except when
the disk protrusion occupies the inter-vertebral foramen and
damages the sensory ganglion or its blood supply. In acute
plexopathies, such as Parsonage–Turner syndrome, the examiner
has to be careful to let sufficient time pass before diagnosing a
postganglionic lesion since sensory denervation, whenever it
takes place, might appear only after a significant delay (10–
12 days). There are many different forms of presentation of a
Parsonage–Turner syndrome and, in some of them, the expected
postganglionic involvement does not affect any nerve available to
electrodiagnostic studies (except for somatosensory evoked
potentials).Normal tendon jerks require normal sensory conduction up to
the spinal cord or brainstem, in accordance to the type of reflex
examined. Therefore, if a patient complains of absent sensation
and the tendon jerks are normal (or enhanced), the cause of the
defective sensation must be in the central nervous system. If in
doubt, the use of an oscilloscope sweep-triggering hammer may
be of interest to obtain the latency of the muscle response to the
tendon tap (Péréon et al., 2004). In limb muscles, the presence of
a normal silent period to electrical stimulation indicates normal
afferent inputs not only for large fibers but also for small fibers
(Kofler, 2003; Lopergolo et al., 2015). Cutaneous reflexes such as
the long latency reflexes of hand muscles (Deuschl and Lücking,
1990; Chen and Ashby, 1993) may also be useful to disclose
absence of damage in the segments of the sensory system
involved in the reflex. For cranial nerve involvement, the examiner
can use the cutaneous reflexes conveyed by the trigeminal nerve
(Valls-Solé, 2005). The assessment should not be limited to the
blink reflex recorded in the orbicularis oculi to supraorbital nerve
stimuli since this can be normal in patients complaining of
defective sensation in the lower face (for instance, in a case of
connective tissue disease). The masseteric inhibitory reflex is more
appropriate in those cases. Arguably, the most ubiquitous reflex
response obtainable in the human body to any type of sensory
stimulation is the sudomotor skin response (Vetrugno et al.,
2003). This is recorded from the palm of the hand, referenced to
the dorsum. In a case of suspected sensory deficit in a certain
region of the body, application of a light electrical stimulus or a
mechanical stimulus in that region should induce a normal
sudomotor skin response in patients complaining of sensory deficit
unrelated to a neurological disorder – a kind of lie-detector test
(Ambach et al., 2008).
3.2. Somatosensory evoked potentials
Damage in the afferent spinal pathways could give rise to
sensory deficit mostly in the lower limbs but also in the upper
limbs if the lesion is at the cervical level. This is usually clinically
evident but there can be situations in which the clinical deficit is
not so obvious. The recording of somatosensory evoked potentials
(SEPs) to electrical nerve stimulation may reveal conduction block
along the dorsal columns. Normality of the SEPs should not be
equated to absence of sensory deficit. Because of the well-known
amplification of the signal along synapses leading the impulses
toward the central nervous system, the SEPs may be normal even
in patients with relevant sensory deficit. SEPs will be normal also
in patients with damage in the antero-lateral pathway, as in
syringomyelia (Treede et al., 1991) or the Wallenberg syndrome
(Veciana et al., 2005). In these cases, nociceptive evoked potentials
are needed to reveal the dysfunction. The most commonly used
stimuli for the assessment of the nociceptive pathway are laser,
which lead to laser evoked potentials (Treede, 2003) and
thermodes that lead to contact heat evoked potentials (Atherton
et al., 2007). Both of them are useful for the study of the nocicep-
tive pathway but the examiner has to be aware that either laser or
contact heat evoked potentials are actually long-latency evoked
potentials, with more variability and, therefore, less precise latency
values, than short-latency somatosensory evoked potentials.
Nevertheless, they still are nowadays one of the most adequate
means to document dysfunction in patients with neuropathic pain
of peripheral or central origin (Baumgärtner et al., 2012).
Long-latency potentials involve some cerebral processing of
sensory stimuli. Such processing may be diminished by diminished
attention to the stimulus, as may occur in some patients with
posttraumatic stress disorder (Felmingham et al., 2002). Instead,
patients with factitious disorders or malingering, who voluntarily
try to avoid any reaction to the stimulus may nevertheless
J. Valls-Solé / Clinical Neurophysiology Practice 1 (2016) 2–8 7generate an event-related potential to the avoidance reaction, and
this remains time-locked to the stimulus. The P300 is generated in
a cognitive task in which the subject has to pay attention and react
to the presentation of an infrequent stimulus, which characteristics
differ from those of a frequent one. In cases in which the subject
tries actively to avoid any reaction, the P300 still appears with
no differences in amplitude in comparison to trials with reaction
(Zarkowski et al., 2007; Hoover et al., 2014).3.3. Prepulse and gating effects
A sensory stimulus activates axon terminals, nerves and spinal
tracts to reach cerebral sensory centers. Along this path, the
traveling impulse generates action potentials and somatosensory
evoked potentials that can be recorded with appropriately located
recording electrodes. Apart from that, they may also generate
reflex responses in the motor system at different points along the
path if the sensory stimulus is of an intensity above threshold for
activation of the motor system. Two of these responses are the
blink reflex and the startle reaction. Both, the generation of long
latency SEPs and the elicitation of reflex responses result from pro-
cessing of the sensory stimulus within the central nervous system,
one toward the brain cognitive areas, another toward the motor
system. The concepts of prepulse and gating refer to how another
sensory stimulus affects such processing. Prepulse effects are those
observed in the response to a suprathreshold stimulus (pulse)
when it is preceded by a stimulus of the same or other modality,
subthreshold for elicitation of a motor response (prepulse). Gating
effects are those observed in the somatosensory evoked potentials
related to a certain stimulus when another stimulus is applied
time-locked to them (afferent gating) or when the subject is mov-
ing (efferent gating). Inhibition is the best known aspect of the two
phenomena.
Prepulse inhibition is an ubiquitous phenomenon that is
characterized by the inhibition of the blink reflex and the startle
reaction induced by either auditory or somatosensory stimuli
(Valls-Solé et al., 1999). The effect means that the stimulus used
as prepulse, which may be auditory, somatosensory, nociceptive
or others (Valls-Solé, 2012), has reached the central nervous sys-
tem and has been effectively integrated in prepulse circuits. There-
fore, the method can be used to test sensation in the specific
sensory modality of the prepulse stimulus and in the precise site
where it has been applied. The method cannot tell, though, any-
thing about conscious perception since the time interval for the
effects to occur (usually 100 ms for auditory or electrical stimuli)
remains in the preconscious domain. Furthermore, it is a qualita-
tive phenomenon, which, per definition, occurs with the activation
of only a small number of afferent axons, insufficient to generate a
response. Inhibitory prepulse is sometimes used interchangeably
with afferent gating to refer to the effects of a sensory stimulus
on the cerebral evoked potentials generated by another stimulus.
This may be the case for the P50 potential to auditory stimuli
(Oranje et al., 2006). However, sensory gating and prepulse inhibi-
tion may be differentially affected in some conditions, such as
schizophrenia (Braff et al., 2007). We have referred above to a type
of sensory abnormality in patients with functional movement
disorders that consists in the lack of sensory attenuation during
voluntary movement. In fact, it has been shown in these patients
there may be no amplitude reduction of the somatosensory evoked
potentials when a stimulus is applied just after onset of a voluntary
movement (Macerollo et al., 2015b). Gating mechanisms are influ-
enced by the subject’s emotional state (Cromwell and Atchley,
2015), which may contribute to explaining the abnormalities in
high-level processing of sensory information in these patients.
The study of the sense of agency during voluntary movements islikely a key point in further understanding the pathophysiological
mechanisms of psychogenic disorders.
4. Conclusions
The results of an electrodiagnostic examination make sense
only if they are based on clinical logic. With this reasoning in mind,
the electrodiagnostic practitioner should use not only data from
electrodiagnostic testing, but also from patient’s history and phys-
ical examinations, to decide on the steps of further testing and
finally issue a clinically relevant report. One of the most important
assets of an electrodiagnostic examination is the avoidance of bias
and of errors related to a premature clinical diagnosis. The electro-
diagnostic examination requires undressing of some body parts
and probing nerve function with stimuli inducing movements or
generating sensory experiences. Therefore, the electrodiagnostic
expert is in the position to notice subtle signs that could have
passed unnoticed in previous possibly more superficial clinical
examinations. In this context, the electrodiagnostic expert should
consider the possibility of false weakness and sensory deficit or,
to be more comprehensive, that some of the weakness and sensory
deficit that the patient refers may not be related to a known neu-
rological disorder. Electrodiagnostic practitioners should not be
misled by clinical appearance in potentially fake symptoms or
signs but, instead, identify them and try to document the condition
on the bases of a good combination of clinical and technical knowl-
edge, and use reason to avoid producing confounding EMG reports.
If and when detected, it is not the function of the electrodiagnostic
examiner to search for the possible cause of the disorder. Instead,
the interpretation of the results should be related to pathophysio-
logical mechanisms explaining symptoms and signs.
In some countries, patients referred for electrodiagnostic
studies may not have yet had a thorough physical neurological
examination that usually sets the bases for a suspected disease.
In this case, to be of help to the patient and to the referring
physician, the electrodiagnostic examiner must be proactive in
the diagnosis and not limit his/her intervention to the requested
tests if there are other tests needed to confirm the clinical suspi-
cion of an alternative diagnosis. The results of the electrodiagnostic
examination may come as a plus on the data obtained with the
clinical examination. If suspicion of neurologically unexplained
weakness or sensory deficit has arisen, the examiner should find
means to warn the referring physician about the possibility of a
functional disorder as the basis of the patient’s symptoms, beyond
just reporting the crude and cold data obtained from the
electrodiagnostic examination.
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